Cited by 1,010SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesAdvanced Proteomics Techniques and Applications

The DOI matches its Crossref record; 51 of the 53 references it cites were found in a registry or an index.

Proteomics of SARS-CoV-2-infected host cells reveals therapy targets

Open access

Bojkova, Denisa, Klann, Kevin, Koch, Benjamin, Widera, Marek, Krause, David, Ciesek, Sandra, Cinatl, Jindrich, Münch, Christian·2020·Nature

DOI 10.1038/s41586-020-2332-7PMC PMC7616921

Published version of a preprint

Open this paper in CoChat — free account Open PDF

Abstract

A new coronavirus was recently discovered and named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Infection with SARS-CoV-2 in humans causes coronavirus disease 2019 (COVID-19) and has been rapidly spreading around the globe 1,2. SARS-CoV-2 shows some similarities to other coronaviruses; however, treatment options and an understanding of how SARS-CoV-2 infects cells are lacking. Here we identify the host cell pathways that are modulated by SARS-CoV-2 and show that inhibition of these pathways prevents viral replication in human cells. We established a human cell-culture model for infection with a clinical isolate of SARS-CoV-2. Using this cell-culture system, we determined the infection profile of SARS-CoV-2 by translatome 3 and proteome proteomics at different times after infection. These analyses revealed that SARS-CoV-2 reshapes central cellular pathways such as translation, splicing, carbon metabolism, protein homeostasis (proteostasis) and nucleic acid metabolism. Small-molecule inhibitors that target these pathways prevented viral replication in cells. Our results reveal the cellular infection profile of SARS-CoV-2 and have enabled the identification of drugs that inhibit viral replication. We anticipate that our results will guide efforts to understand the molecular mechanisms that underlie the modulation of host cells after infection with SARS-CoV-2. Furthermore, our findings provide insights for the development of therapies for the treatment of COVID-19.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41586-020-2332-7

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Data Structures for Statistical Computing in Python
McKinney, W. (2010) · Proceedings of the Python in Science Conferences · doi:10.25080/majora-92bf1922-00a · Cited by 12,930
The NumPy Array: A Structure for Efficient Numerical Computation
van der Walt, S., Colbert, S. C., & Varoquaux, G. (2011) · Computing in Science & Engineering · doi:10.1109/mcse.2011.37 · Cited by 9,381
The Perseus computational platform for comprehensive analysis of (prote)omics data
Tyanova, S., Temu, T., Sinitcyn, P., Carlson, A., Hein, M. Y., Geiger, T., Mann, M., & Cox, J. (2016) · Nature Methods · doi:10.1038/nmeth.3901 · Cited by 8,803
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
Chan, J., Yuan, S.-F., Kok, K.-H., To, K., Chu, H., Yang, J., Xing, F., Liu, J.-L., Yip, C., Poon, R., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30154-9 · Cited by 8,450
A scaling normalization method for differential expression analysis of RNA-seq data
Robinson, M. D., & Oshlack, A. (2010) · Genome Biology · doi:10.1186/gb-2010-11-3-r25 · Cited by 7,876

Show all 53 references

Sorted by citations

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature · doi:10.1038/s41586-020-2286-9 · Cited by 4,405
Coronavirus biology and replication: implications for SARS-CoV-2
V’kovski, P., Kratzel, A., Steiner, S., Stalder, H., & Thiel, V. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00468-6 · Cited by 3,371
Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity
Shin, D., Mukherjee, R., Grewe, D., Bojková, D., Baek, K., Bhattacharya, A., Schulz, L., Widera, M., Mehdipour, A. R., Tascher, G., et al. (2020) · Nature · doi:10.1038/s41586-020-2601-5 · Cited by 1,213
Self-citation
Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis
Codo, A. C., Davanzo, G. G., Monteiro, L. D. B., de Souza, G. F., Muraro, S. P., Virgilio-da-Silva, J. V., Prodonoff, J. S., Carregari, V. C., de Biagi Junior, C. A. O., Crunfli, F., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.07.007 · Cited by 733
The coding capacity of SARS-CoV-2
Finkel, Y., Mizrahi, O., Nachshon, A., Weingarten-Gabbay, S., Morgenstern, D., Yahalom-Ronen, Y., Tamir, H., Achdout, H., Stein, D., Israeli, O., et al. (2021) · Nature · doi:10.1038/s41586-020-2739-1 · Cited by 644
Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV
Stukalov, A., Girault, V., Grass, V., Karayel, Ö., Bergant, V., Urban, C., Haas, D. A., Huang, Y., Oubraham, L., Wang, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03493-4 · Cited by 656
SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19
Zhang, S., Liu, Y., Wang, X., Li, H., Li, H., Wang, Y., Liu, M., Zhao, X., Xie, Y., Yang, Y., et al. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00954-7 · Cited by 673
In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges
Turoňová, B., Sikora, M., Schürmann, C., Hagen, W. J. H., Welsch, S., Blanc, F. E. C., von Bülow, S., Gecht, M., Bagola, K., Hörner, C., et al. (2020) · Science · doi:10.1126/science.abd5223 · Cited by 641
Structures and functions of coronavirus replication–transcription complexes and their relevance for SARS-CoV-2 drug design
Malone, B. F., Urakova, N., Snijder, E. J., & Campbell, E. A. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00432-z · Cited by 583
The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι
Zhang, Y., Chen, Y., Li, Y., Huang, F., Luo, B., Yuan, Y., Xia, B., Ma, X., Yang, T., Yu, F., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2024202118 · Cited by 553
Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein
Davidson, A. D., Williamson, M. K., Lewis, S., Shoemark, D., Carroll, M. W., Heesom, K. J., Zambon, M., Ellis, J., Lewis, P. A., Hiscox, J. A., et al. (2020) · Genome Medicine · doi:10.1186/s13073-020-00763-0 · Cited by 457
Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19
Yadav, R., Chaudhary, J. K., Jain, N. K., Chaudhary, P. K., Khanra, S., Dhamija, P., Sharma, A., Kumar, A., & Handu, S. S. (2021) · Cells · doi:10.3390/cells10040821 · Cited by 486
Reduced Neutralization of SARS-CoV-2 Omicron Variant by Vaccine Sera and Monoclonal Antibodies
Wilhelm, A., Widera, M., Grikscheit, K., Toptan, T., Schenk, B., Pallas, C., Metzler, M., Kohmer, N., Hoehl, S., Helfritz, F. A., et al. (2021) · doi:10.1101/2021.12.07.21267432 · Cited by 440
Self-citation
Multi-organ proteomic landscape of COVID-19 autopsies
Nie, X., Qian, L., Sun, R., Huang, B., Dong, X., Xiao, Q., Zhang, Q., Lu, T., Yue, L., Chen, S., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.004 · Cited by 403
A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-RepurposingPreprint
Gordon, D. E., Jang, G. Μ., Bouhaddou, M., Xu, J., Obernier, K., O’Meara, M. J., Guo, J. Z., Swaney, D. L., Tummino, T. A., Hüttenhain, R., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.22.002386 · Cited by 419
Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis
Li, J., Guo, M., Tian, X., Wang, X., Yang, X., Wu, P., Liu, C., Xiao, Z., Qu, Y., Yin, Y., et al. (2020) · Med · doi:10.1016/j.medj.2020.07.002 · Cited by 361
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
White, K. M., Rosales, R., Yildiz, S., Kehrer, T., Miorin, L., Moreno, E., Jangra, S., Uccellini, M. B., Rathnasinghe, R., Coughlan, L., et al. (2021) · Science · doi:10.1126/science.abf4058 · Cited by 348
Morphological, cellular and molecular basis of brain infection in COVID-19 patients
Crunfli, F., Carregari, V. C., Veras, F. P., Vendramini, P. H., Valença, A. G. F., Antunes, A. S. L. M., Brandão-Teles, C., da Silva Zuccoli, G., Reis-de-Oliveira, G., Silva-Costa, L. C., et al. (2020) · doi:10.1101/2020.10.09.20207464 · Cited by 331
The SARS-CoV-2 RNA–protein interactome in infected human cells
Schmidt, N., Lareau, C. A., Keshishian, H., Ganskih, S., Schneider, C., Hennig, T., Melanson, R., Werner, S., Wei, Y., Zimmer, M., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-00846-z · Cited by 319
A metabolic handbook for the COVID-19 pandemic
Ayres, J. S. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0237-2 · Cited by 293
Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system
Yeung, M. L., Teng, J. L. L., Jia, L., Zhang, C., Huang, C., Cai, J., Zhou, R., Chan, K., Zhao, H., Zhu, L., et al. (2021) · Cell · doi:10.1016/j.cell.2021.02.053 · Cited by 276
Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications
Trougakos, I. P., Stamatelopoulos, K. S., Terpos, E., Tsitsilonis, O., Aivalioti, E., Paraskevis, D. N., Kastritis, E., Pavlakis, G. N., & Dimopoulos, M. A. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-020-00703-5 · Cited by 305
Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells
Appelberg, S., Gupta, S., Akusjärvi, S. S., Ambikan, A. T., Mikaeloff, F., Saccon, E., Végvári, Á., Benfeitas, R., Sperk, M., Ståhlberg, M., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1799723 · Cited by 276
METTL3 regulates viral m6A RNA modification and host cell innate immune responses during SARS-CoV-2 infection
Li, N., Hui, H., Bray, B., Gonzalez, G. M., Zeller, M., Anderson, K. G., Knight, R. D., Smith, D. M., Wang, Y., Carlin, A. F., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109091 · Cited by 283
SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes
Bojkova, D., Wagner, J. U. G., Shumliakivska, M., Aslan, G. S., Saleem, U., Hansen, A., Luxán, G., Günther, S., Pham, M. D., Krishnan, J., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa267 · Cited by 257
Self-citation
SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO
Wu, J., Shi, Y., Pan, X., Wu, S., Hou, R., Zhang, Y., Zhong, T., Tang, H., Du, W., Wang, L., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108761 · Cited by 278
SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis
Finkel, Y., Gluck, A., Nachshon, A., Winkler, R., Fisher, T., Rozman, B., Mizrahi, O., Lubelsky, Y., Zuckerman, B., Slobodin, B., et al. (2021) · Nature · doi:10.1038/s41586-021-03610-3 · Cited by 253
Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning
Zeng, X., Song, X. H., Ma, T., Pan, X., Zhou, Y., Hou, Y., Zhang, Z., Li, K., Karypis, G., & Cheng, F. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00316 · Cited by 261
HIF-1α promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19
Tian, M., Liu, W., Li, X., Zhao, P., Shereen, M. A., Zhu, C., Huang, S., Liu, S., Yu, X., Yue, M., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00726-w · Cited by 249
The SARS-CoV-2 main protease Mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells
Wenzel, J., Lampe, J., Müller‐Fielitz, H., Schuster, R., Zille, M., Müller, K., Krohn, M., Körbelin, J., Zhang, L., Özorhan, Ü., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00926-1 · Cited by 259
Self-citation
Growth Factor Receptor Signaling Inhibition Prevents SARS-CoV-2 Replication
Klann, K., Bojková, D., Tascher, G., Ciesek, S., Münch, C., & Cinatl, J. J. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.08.006 · Cited by 237
Self-citation
In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs
Sun, L., Li, P., Ju, X., Rao, J. Y., Huang, W., Ren, L., Zhang, S., Xiong, T., Xu, K., Zhou, X., et al. (2021) · Cell · doi:10.1016/j.cell.2021.02.008 · Cited by 229
A high-stringency blueprint of the human proteome
Adhikari, S., Nice, E. C., Deutsch, E. W., Lane, L., Omenn, G. S., Pennington, S. R., Paik, Y.-K., Overall, C. M., Corrales, F. J., Cristea, I. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19045-9 · Cited by 210
Metformin in COVID-19: A possible role beyond diabetes
Sharma, S., Ray, A., & Sadasivam, B. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108183 · Cited by 202
A comprehensive SARS-CoV-2–human protein–protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets
Zhou, Y., Liu, Y., Gupta, S., Paramo, M. I., Hou, Y., Mao, C., Luo, Y., Judd, J., Wierbowski, S. D., Bertolotti, M., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01474-0 · Cited by 214
Serum Proteomics in COVID-19 Patients: Altered Coagulation and Complement Status as a Function of IL‑6 Level
D’Alessandro, A., Thomas, T. A., Dzieciątkowska, M., Hill, R. C., Francis, R. O., Hudson, K. E., Zimring, J. C., Hod, E. A., Spitalnik, S. L., & Hansen, K. C. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00365 · Cited by 195
SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development
Murgolo, N., Therien, A. G., Howell, B. J., Klein, D. J., Koeplinger, K. A., Lieberman, L. A., Adam, G. C., Flynn, J. A., McKenna, P. M., Swaminathan, G., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009225 · Cited by 204
Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts
Guarnieri, J. W., Dybas, J. M., Fazelinia, H., Kim, M. S., Frere, J. J., Zhang, Y., Albrecht, Y. E. S., Murdock, D. G., Angelin, A., Singh, L. N., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abq1533 · Cited by 235
Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19
Scozzi, D., Cano, M., Ma, L., Zhou, D., Zhu, J. H., O’Halloran, J. A., Goss, C. W., Rauseo, A. M., Liu, Z., Sahu, S. K., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.143299 · Cited by 181
SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes
Jungreis, I., Sealfon, R. S. G., & Kellis, M. (2021) · Nature Communications · doi:10.1038/s41467-021-22905-7 · Cited by 193
A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19
Zhou, Y., Hou, Y., Shen, J., Mehra, R., Kallianpur, A., Culver, D. A., Gack, M. U., Farha, S., Zein, J., Comhair, S., et al. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000970 · Cited by 180
The SARS-CoV-2 RNA interactome
Lee, S., Lee, Y.-S., Choi, Y., Son, A., Park, Y., Lee, K., Kim, J., Kim, J., & Kim, V. N. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.04.022 · Cited by 178
Low high-density lipoprotein level is correlated with the severity of COVID-19 patients: an observational study
Wang, G., Zhang, Q., Zhao, X., Dong, H., Wu, C., Wu, F., Yu, B., Lv, J., Zhang, S., Wu, G., et al. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01382-9 · Cited by 172
Potential protective mechanisms of green tea polyphenol EGCG against COVID-19
Zhang, Z., Zhang, X., Bi, K., He, Y., Yan, W., Yang, C. S., & Zhang, J. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.05.023 · Cited by 173
Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment
Zhou, Y., Xu, J., Hou, Y., Leverenz, J. B., Kallianpur, A. R., Mehra, R., Liu, Y., Yu, H., Pieper, A. A., Jehi, L. E., et al. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00850-3 · Cited by 165
Global analysis of protein-RNA interactions in SARS-CoV-2-infected cells reveals key regulators of infection
Kamel, W., Noerenberg, M., Cerikan, B., Chen, H., Järvelin, A. I., Kammoun, M., Lee, Y. S., Ni, S., García-Moreno, M., Andrejeva, A., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.05.023 · Cited by 157
Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway
Daamen, A. R., Bachali, P., Owen, K. A., Kingsmore, K. M., Hubbard, E. L., Labonte, A. C., Robl, R. D., Shrotri, S., Grammer, A. C., & Lipsky, P. E. (2021) · Scientific Reports · doi:10.1038/s41598-021-86002-x · Cited by 151
Lack of antiviral activity of darunavir against SARS-CoV-2
Meyer, S. D., Bojková, D., Cinatl, J. J., Damme, E. V., Buyck, C., Loock, M. V., Woodfall, B., & Ciesek, S. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.05.085 · Cited by 148
Self-citation
SARS-CoV-2 disrupts host epigenetic regulation via histone mimicry
Kee, J., Thudium, S., Renner, D. M., Glastad, K. M., Palozola, K. C., Zhang, Z., Li, Y., Lan, Y., Cesare, J., Poleshko, A. S., et al. (2022) · Nature · doi:10.1038/s41586-022-05282-z · Cited by 145
Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell
Puray‐Chavez, M., LaPak, K. M., Schrank, T. P., Elliott, J. L., Bhatt, D. P., Agajanian, M. J., Jasuja, R., Lawson, D. Q., Davis, K., Rothlauf, P. W., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109364 · Cited by 139
The key role of Warburg effect in SARS-CoV-2 replication and associated inflammatory response
Icard, P., Lincet, H., Wu, Z., Coquerel, A., Forgez, P., Alifano, M., & Fournel, L. (2020) · Biochimie · doi:10.1016/j.biochi.2020.11.010 · Cited by 141
Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoVPreprint
Stukalov, A., Girault, V., Grass, V., Karayel, O., Bergant, V., Urban, C., Haas, D. A., Huang, Y., Oubraham, L., Wang, A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.17.156455 · Cited by 144
Establishing a mass spectrometry-based system for rapid detection of SARS-CoV-2 in large clinical sample cohorts
Cardozo, K. H. M., Lebkuchen, A., Okai, G. G., Schuch, R. A., Viana, L. G., Olivé, A. N., Lázari, C. D. S., Fraga, A., Granato, C. F. H., Pintão, M. C. T., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19925-0 · Cited by 135
Multi-level inhibition of coronavirus replication by chemical ER stress
Shaban, M. S., Müller, C., Mayr‐Buro, C., Weiser, H., Meier‐Soelch, J., Albert, B. V., Weber, A., Linne, U., Hain, T., Babayev, I., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25551-1 · Cited by 133
S-acylation controls SARS-CoV-2 membrane lipid organization and enhances infectivity
Mesquita, F. S., Abrami, L., Sergeeva, O. A., Turelli, P., Qing, E., Kunz, B., Raclot, C., Montoya, J. P., Abriata, L. A., Gallagher, T., et al. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.09.016 · Cited by 129
Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Nonstructural Proteins Identifies Unique and Shared Host-Cell Dependencies
Davies, J. P., Almasy, K. M., McDonald, E. F., & Plate, L. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00500 · Cited by 128
Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents
Khadke, S., Ahmed, N., Ahmed, N., Ratts, R., Raju, S., Gallogly, M. M., Lima, M. J. G. D., & Sohail, M. R. (2020) · Virology Journal · doi:10.1186/s12985-020-01415-w · Cited by 127
Understanding the Role of SARS-CoV-2 ORF3a in Viral Pathogenesis and COVID-19
Zhang, J., Ejikemeuwa, A., Gerzanich, V., Nasr, M., Tang, Q., Simard, J. M., & Zhao, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.854567 · Cited by 138
GCG inhibits SARS-CoV-2 replication by disrupting the liquid phase condensation of its nucleocapsid protein
Zhao, M., Yu, Y., Sun, L.-M., Xing, J., Li, T., Zhu, Y., Wang, M., Yu, Y., Xue, W., Xia, T., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22297-8 · Cited by 119
The trans-omics landscape of COVID-19
Wu, P., Chen, D., Ding, W., Wu, P., Hou, H., Bai, Y., Zhou, Y., Li, K., Xiang, S., Liu, P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24482-1 · Cited by 122
Clinical Evaluation of BD Veritor SARS-CoV-2 Point-of-Care Test Performance Compared to PCR-Based Testing and versus the Sofia 2 SARS Antigen Point-of-Care Test
Young, S. A., Taylor, S. N., Cammarata, C. L., Varnado, K. G., Roger-Dalbert, C., Montano, A., Griego-Fullbright, C., Burgard, C., Fernandez, C., Eckert, K., et al. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.02338-20 · Cited by 122
A cross-talk between epithelium and endothelium mediates human alveolar–capillary injury during SARS-CoV-2 infection
Wang, P., Luo, R., Zhang, M., Wang, Y., Song, T., Tao, T., Li, Z., Jin, L., Zheng, H., Chen, W., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03252-9 · Cited by 118
A critical review on SARS-CoV-2 infectivity in water and wastewater. What do we know?
Giacobbo, A., Rodrigues, M. A. S., Ferreira, J. Z., Bernardes, A. M., & de Pinho, M. N. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.145721 · Cited by 122
SARS-CoV-2 infection drives an inflammatory response in human adipose tissue through infection of adipocytes and macrophages
Martínez-Colón, G. J., Ratnasiri, K., Chen, R., Jiang, S., ZANLEY, E. J., Rustagi, A., Verma, R., Chen, H. M., Andrews, J. R., Mertz, K. D., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abm9151 · Cited by 140
Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2
Hekman, R. M., Hume, A. J., Goel, R. K., Abo, K. M., Huang, J., Blum, B. C., Werder, R. B., Suder, E. L., Paul, I., Phanse, S., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.11.028 · Cited by 115
Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential
Meyer, B., Chiaravalli, J., Gellenoncourt, S., Brownridge, P., Bryne, D. P., Daly, L. A., Grauslys, A., Walter, M., Agou, F., Chakrabarti, L. A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25796-w · Cited by 119
Metabolic Perturbation Associated With COVID-19 Disease Severity and SARS-CoV-2 Replication
Krishnan, S., Nordqvist, H., Ambikan, A. T., Gupta, S., Sperk, M., Akusjärvi, S. S., Mikaeloff, F., Benfeitas, R., Saccon, E., Ponnan, S. M., et al. (2021) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2021.100159 · Cited by 112
Sensing of cytoplasmic chromatin by cGAS activates innate immune response in SARS-CoV-2 infection
Zhou, Z. L., Zhang, X., Lei, X., Xiao, X., Jiao, T., Ma, R., Dong, X., Jiang, Q., Wang, W., Shi, Y., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00800-3 · Cited by 120
Exploring the antibacterial mechanism of essential oils by membrane permeability, apoptosis and biofilm formation combination with proteomics analysis against methicillin-resistant staphylococcus aureus
Tang, C., Chen, J., Zhang, L., Zhang, R., Zhang, S., Ye, S., Zhao, Z., & Yang, D. (2020) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2020.151435 · Cited by 117
Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses
Hu, Y., Ma, C., Szeto, T., Hurst, B. L., Tarbet, E. B., & Wang, J. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00761 · Cited by 115
Comparison of viral RNA–host protein interactomes across pathogenic RNA viruses informs rapid antiviral drug discovery for SARS-CoV-2
Zhang, S., Huang, W., Ren, L., Ju, X., Gong, M., Rao, J. Y., Sun, L., Li, P., Ding, Q., Wang, J., et al. (2021) · Cell Research · doi:10.1038/s41422-021-00581-y · Cited by 119
Mitochondria: In the Cross Fire of SARS-CoV-2 and Immunity
Burtscher, J., Cappellano, G., Omori, A., Koshiba, T., & Millet, G. P. (2020) · iScience · doi:10.1016/j.isci.2020.101631 · Cited by 110
Replication kinetics and infectivity of SARS-CoV-2 variants of concern in common cell culture models
Mautner, L., Hoyos, M., Dangel, A., Berger, C., Ehrhardt, A., & Baiker, A. E. (2022) · Virology Journal · doi:10.1186/s12985-022-01802-5 · Cited by 107
Metabolomic analyses reveal new stage-specific features of COVID-19
Jia, H.-L., Liu, C., Li, D., Huang, Q., Liu, D., Zhang, Y., Ye, C., Zhou, D., Wang, Y., Tan, Y., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.00284-2021 · Cited by 103
SARS-CoV-2 Antiviral Therapy
Tao, K., Tzou, P. L., Nouhin, J., Bonilla, H. F., Jagannathan, P., & Shafer, R. W. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00109-21 · Cited by 109
Proteotyping SARS-CoV‑2 Virus from Nasopharyngeal Swabs: A Proof-of-Concept Focused on a 3 Min Mass Spectrometry Window
Gouveia, D., Miotello, G., Gallais, F., Gaillard, J., Debroas, S., Bellanger, L., Lavigne, J., Sotto, A., Grenga, L., Pible, O., et al. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00535 · Cited by 102
Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes
Poran, A., Harjanto, D., Malloy, M., Arieta, C. M., Rothenberg, D. A., Lenkala, D., van Buuren, M. M., Addona, T. A., Rooney, M. S., Srinivasan, L., et al. (2020) · Genome Medicine · doi:10.1186/s13073-020-00767-w · Cited by 101
Development strategies of conducting polymer-based electrochemical biosensors for virus biomarkers: Potential for rapid COVID-19 detection
Tran, V. V., Tran, N. H. T., Hwang, H. S., & Chang, M. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113192 · Cited by 103
Direct RNA sequencing and early evolution of SARS-CoV-2Preprint
Taiaroa, G., Rawlinson, D., Featherstone, L. A., Pitt, M. E., Caly, L., Druce, J. D., Purcell, D. F. J., Harty, L., Tran, T., Roberts, J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.05.976167 · Cited by 101
Mechanistic insight into substrate processing and allosteric inhibition of human p97
Pan, M., Yu, Y., Ai, H., Zheng, Q., Xie, Y., Liu, L., & Zhao, M. (2021) · Nature Structural & Molecular Biology · doi:10.1038/s41594-021-00617-2 · Cited by 89
The Mechanism of SARS-CoV-2 Nucleocapsid Protein Recognition by the Human 14-3-3 Proteins
Tugaeva, K. V., Hawkins, D. E. D. P., Smith, J. L. R., Bayfield, O. W., Ker, D.-S., Sysoev, A. A., Klychnikov, O. I., Antson, A. A., & Sluchanko, N. N. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.166875 · Cited by 95
RNA G-quadruplex in TMPRSS2 reduces SARS-CoV-2 infection
Liu, G., Du, W., Sang, X., Tong, Q., Wang, Y., Chen, G., Yuan, Y., Jiang, L., Cheng, W., Liu, D., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29135-5 · Cited by 98
Comprehensive mapping of SARS-CoV-2 interactions in vivo reveals functional virus-host interactions
Yang, S. L., DeFalco, L., Anderson, D. E., Zhang, Y., Aw, J. G. A., Lim, S. Y., Lim, X. N., Tan, K. Y., Zhang, T., Chawla, T., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25357-1 · Cited by 94
Dynamically evolving novel overlapping gene as a factor in the SARS-CoV-2 pandemic
Nelson, C. W., Ardern, Z., Goldberg, T. L., Meng, C., Kuo, C.-H., Ludwig, C., Kolokotronis, S.-O., & Wei, X. (2020) · eLife · doi:10.7554/elife.59633 · Cited by 87
The SARS-CoV-2 ORF10 is not essential in vitro or in vivo in humans
Pancer, K., Milewska, A., Owczarek, K., Dabrowska, A., Kowalski, M., Łabaj, P. P., Branicki, W., Sanak, M., & Pyrc, K. (2020) · PLOS Pathogens · doi:10.1371/journal.ppat.1008959 · Cited by 83
Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19
Barh, D., Tiwari, S., Weener, M. E., Azevedo, V., Góes-Neto, A., Gromiha, M. M., & Ghosh, P. (2020) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2020.104051 · Cited by 90
Hyperinflammation and Fibrosis in Severe COVID-19 Patients: Galectin-3, a Target Molecule to Consider
García‐Revilla, J., Deierborg, T., Venero, J. L., & Boza‐Serrano, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02069 · Cited by 92
Interactomes of SARS‐CoV‐2 and human coronaviruses reveal host factors potentially affecting pathogenesis
Chen, Z., Wang, C., Feng, X., Nie, L., Tang, M., Zhang, H., Xiong, Y., Swisher, S. K., Srivastava, M., & Chen, J. (2021) · The EMBO Journal · doi:10.15252/embj.2021107776 · Cited by 103
DeepIPs: comprehensive assessment and computational identification of phosphorylation sites of SARS-CoV-2 infection using a deep learning-based approach
Lv, H., Dao, F., Zulfiqar, H., & Lin, H. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab244 · Cited by 91
A high-resolution temporal atlas of the SARS-CoV-2 translatome and transcriptome
Kim, D., Kim, S., Park, J., Chang, H. R., Chang, J., Ahn, J., Park, H., Park, J., Son, N., Kang, G., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25361-5 · Cited by 88
The Role of Tricarboxylic Acid Cycle Metabolites in Viral Infections
Sánchez‐García, F. J., Pérez-Hernández, C. A., Rodríguez-Murillo, M., & Moreno‐Altamirano, M. M. B. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.725043 · Cited by 89
The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection
Arieta, C. M., Xie, Y. J., Rothenberg, D., Diao, H., Harjanto, D., Meda, S., Marquart, K., Koenitzer, B., Sciuto, T. E., Lobo, A., et al. (2023) · Cell · doi:10.1016/j.cell.2023.04.007 · Cited by 88
In Vitro and In Vivo Models for Studying SARS-CoV-2, the Etiological Agent Responsible for COVID-19 Pandemic
Rosa, R. B., Dantas, W. M., do Nascimento, J. C. F., da Silva, M. V., de Oliveira, R. N., & Pena, L. (2021) · Viruses · doi:10.3390/v13030379 · Cited by 89
Comparative Genomic Analysis of Rapidly Evolving SARS-CoV-2 Reveals Mosaic Pattern of Phylogeographical Distribution
Kumar, R., Verma, H., Singhvi, N., Sood, U., Gupta, V., Singh, M., KUMARI, R. R., Hira, P., Nagar, S., Talwar, C., et al. (2020) · mSystems · doi:10.1128/msystems.00505-20 · Cited by 81
Aprotinin Inhibits SARS-CoV-2 Replication
Bojkova, D., Bechtel, M., McLaughlin, K.-M., McGreig, J. E., Klann, K., Bellinghausen, C., Rohde, G., Jonigk, D., Braubach, P., Ciesek, S., et al. (2020) · Cells · doi:10.3390/cells9112377 · Cited by 84
Self-citation
ATR-FTIR spectrum analysis of saliva samples from COVID-19 positive patients
Martínez-Cuazitl, A., Vázquez-Zapién, G. J., Sánchez-Brito, M., Limón-Pacheco, J. H., Guerrero-Ruiz, M., Garibay-Gonzalez, F., Delgado-Macuil, R. J., de Jesus, M. G., Corona-Perezgrovas, M. Á., Pereyra-Talamantes, A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-99529-w · Cited by 83
SARS-CoV-2 Disrupts Proximal Elements in the JAK-STAT Pathway
Chen, D. W., Khan, N., Close, B. J., Goel, R. K., Blum, B. C., Tavares, A. H., Kenney, D., Conway, H. L., Ewoldt, J. K., Chitalia, V. C., et al. (2021) · Journal of Virology · doi:10.1128/jvi.00862-21 · Cited by 81
Hallmarks of Metabolic Reprogramming and Their Role in Viral Pathogenesis
Allen, C. N. S., Arjona, S. P., Santerre, M., & Sawaya, B. E. (2022) · Viruses · doi:10.3390/v14030602 · Cited by 85
COVID-19 drug discovery and treatment options
Chan, J. F., Yuan, S., Chu, H., Sridhar, S., & Yuen, K. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01036-y · Cited by 92
Drug targets for COVID-19 therapeutics: Ongoing global efforts
Saxena, A. (2020) · Journal of Biosciences · doi:10.1007/s12038-020-00067-w · Cited by 84

Authors: Bojkova, D., Klann, K., Koch, B., Widera, M., Krause, D., Ciesek, S., Cinatl, J., & Münch, C.
Affiliations: Goethe University Frankfurt (DE)
University Hospital Frankfurt (DE)
Corresponding author: Cinatl, Jindrich
Münch, Christian
ORCID: Klann, Kevin
Koch, Benjamin
Widera, Marek
Krause, David
Ciesek, Sandra
Cinatl, Jindrich
Münch, Christian
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2020-05-14
Volume: 583
Issue: 7816
Pages: 469-472
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/s41586-020-2332-7
PMC: PMC7616921
OpenAlex: W3026002191
Cited by: 1,010
References: 53
Citations by year: 2026: 25 · 2025: 58 · 2024: 86 · 2023: 118 · 2022: 198 · 2021: 347 · 2020: 177
FWCI: 27.46
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature (publishedVersion)
Research Square (acceptedVersion, cc-by)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Publikationsdatenbank der Fraunhofer-Gesellschaft (Fraunhofer-Gesellschaft) (submittedVersion)
Fraunhofer-Publica (Fraunhofer-Gesellschaft) (submittedVersion)
Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, cc-by)
Funders: Frankfurter Stiftung für krebskranke Kinder
Hilfe für krebskranke Kinder Frankfurt
European Commission
Deutsche Forschungsgemeinschaft (ERC StG 803565, MU 4216/1-1, CRC 1177)
Aventis Foundation
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
Keywords: SARS-CoV-2, COVID-19 pandemic, viral replication, host-pathogen interaction, translation (biology), splicing, carbon metabolism, proteostasis, nucleic acid metabolism, small molecule inhibitors, antiviral drug targets, proteome, translatome
MeSH terms: Betacoronavirus, Proteostasis, COVID-19, SARS-CoV-2, COVID-19 Drug Treatment, Carbon, Drug Evaluation, Preclinical, Humans, Kinetics, Pneumonia, Viral, RNA Splicing, Time Factors, Protein Biosynthesis, Virus Replication, Coronavirus Infections, Caco-2 Cells, Proteome, Proteomics, Host-Pathogen Interactions, Pandemics, Molecular Targeted Therapy, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Proteomics of SARS-CoV-2-infected host cells reveals therapy targets

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks